Last updated: February 19, 2024
Sponsor: Erasmus Medical Center
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Aging
Macular Degeneration
Geographic Atrophy
Treatment
Risk profiling
Coaching
Standard lifestyle recommendations + dietary supplementation
Clinical Study ID
NCT05667441
NL65052.078.18
MEC-2018-063
Ages 55-85 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Early/Intermediate AMD or unilateral late AMD with minimal vision 0.8
Exclusion
Exclusion Criteria:
- Participation in other intervention studies for AMD
- Living in retirement homes (difficulty in implementation of diet)
- Diagnosis of dementia (because of unreliable dietary recall)
- Persons with macular pathology other than AMD hindering appropriate grading of themacula
- Persons who are illiterate and have no independent trusted person with them to explainthe informed consent form.
- Persons diagnosed with liver and kidney insufficiency.
Study Design
Total Participants: 150
Treatment Group(s): 3
Primary Treatment: Risk profiling
Phase:
Study Start date:
August 01, 2021
Estimated Completion Date:
August 01, 2025
Study Description
Connect with a study center
Erasmus Medical Center
Rotterdam,
NetherlandsSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.